Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CopperTouch is a healthcare technology company focused on reducing healthcare-associated infections (HAIs) through the use of antimicrobial copper surfaces. The company manufactures adhesive-backed copper "skins" designed for high-touch surfaces in clinical environments, such as door handles, IV poles, and bed rails. These products utilize the inherent oligodynamic effect of copper to continuously eliminate pathogens, providing a passive layer of protection between manual cleanings. CopperTouch's solutions are intended to supplement standard hygiene protocols and improve patient safety in hospitals and long-term care facilities. The technology is based on research demonstrating that copper surfaces can significantly reduce the microbial load in hospital settings, and the company's products are EPA-registered for durability in high-traffic medical areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CopperTouch.